Richard S. Levy
2013
In 2013, Richard S. Levy earned a total compensation of $1.7M as Executive Vice President and Chief Drug Development Officer at Incyte, a 26% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $265,933 |
|---|---|
| Option Awards | $1,042,506 |
| Salary | $373,423 |
| Other | $6,664 |
| Total | $1,688,526 |
Levy received $1M in option awards, accounting for 62% of the total pay in 2013.
Levy also received $265.9K in non-equity incentive plan, $373.4K in salary and $6.7K in other compensation.
Rankings
In 2013, Richard S. Levy's compensation ranked 4,492nd out of 12,286 executives tracked by ExecPay. In other words, Levy earned more than 63.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,492 out of 12,286 | 63rd |
Division Services | 715 out of 1,936 | 63rd |
Major group Engineering, Accounting, Research, Management, And Related Services | 55 out of 182 | 70th |
Industry group Research, Development, And Testing Services | 23 out of 63 | 64th |
Industry Commercial Physical and Biological Research | 23 out of 55 | 58th |
Source: SEC filing on April 18, 2016.
Levy's colleagues
We found four more compensation records of executives who worked with Richard S. Levy at Incyte in 2013.